JP4985407B2 - ポリ−γ−グルタミン酸の製造法及びその製造法に用いられる微生物 - Google Patents
ポリ−γ−グルタミン酸の製造法及びその製造法に用いられる微生物 Download PDFInfo
- Publication number
- JP4985407B2 JP4985407B2 JP2007555359A JP2007555359A JP4985407B2 JP 4985407 B2 JP4985407 B2 JP 4985407B2 JP 2007555359 A JP2007555359 A JP 2007555359A JP 2007555359 A JP2007555359 A JP 2007555359A JP 4985407 B2 JP4985407 B2 JP 4985407B2
- Authority
- JP
- Japan
- Prior art keywords
- glutamic acid
- poly
- electron transport
- transport system
- bacillus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000004220 glutamic acid Substances 0.000 title claims description 76
- 244000005700 microbiome Species 0.000 title claims description 24
- 238000000034 method Methods 0.000 title claims description 16
- 239000003112 inhibitor Substances 0.000 claims description 48
- 238000004519 manufacturing process Methods 0.000 claims description 20
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 16
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 claims description 16
- 244000063299 Bacillus subtilis Species 0.000 claims description 14
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 14
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 14
- 229960002504 capsaicin Drugs 0.000 claims description 8
- 235000017663 capsaicin Nutrition 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 5
- 238000012258 culturing Methods 0.000 claims description 4
- FHUDAMLDXFJHJE-UHFFFAOYSA-N 1,1,1-trifluoropropan-2-one Chemical compound CC(=O)C(F)(F)F FHUDAMLDXFJHJE-UHFFFAOYSA-N 0.000 claims 1
- 239000002609 medium Substances 0.000 description 32
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 241001037822 Bacillus bacterium Species 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 238000009825 accumulation Methods 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- TXBBUSUXYMIVOS-UHFFFAOYSA-N thenoyltrifluoroacetone Chemical compound FC(F)(F)C(=O)CC(=O)C1=CC=CS1 TXBBUSUXYMIVOS-UHFFFAOYSA-N 0.000 description 8
- 230000027756 respiratory electron transport chain Effects 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
- 239000006142 Luria-Bertani Agar Substances 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 235000013922 glutamic acid Nutrition 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000013555 soy sauce Nutrition 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 description 3
- 108090000365 Cytochrome-c oxidases Proteins 0.000 description 3
- 102000008013 Electron Transport Complex I Human genes 0.000 description 3
- 108010089760 Electron Transport Complex I Proteins 0.000 description 3
- 102000015782 Electron Transport Complex III Human genes 0.000 description 3
- 108010024882 Electron Transport Complex III Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 3
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 3
- GMPKIPWJBDOURN-UHFFFAOYSA-N Methoxyamine Chemical compound CON GMPKIPWJBDOURN-UHFFFAOYSA-N 0.000 description 3
- 229940123934 Reductase inhibitor Drugs 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229960004194 lidocaine Drugs 0.000 description 3
- 235000013379 molasses Nutrition 0.000 description 3
- 235000013923 monosodium glutamate Nutrition 0.000 description 3
- 239000008057 potassium phosphate buffer Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 229940073490 sodium glutamate Drugs 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 230000002407 ATP formation Effects 0.000 description 2
- UIFFUZWRFRDZJC-UHFFFAOYSA-N Antimycin A1 Natural products CC1OC(=O)C(CCCCCC)C(OC(=O)CC(C)C)C(C)OC(=O)C1NC(=O)C1=CC=CC(NC=O)=C1O UIFFUZWRFRDZJC-UHFFFAOYSA-N 0.000 description 2
- NQWZLRAORXLWDN-UHFFFAOYSA-N Antimycin-A Natural products CCCCCCC(=O)OC1C(C)OC(=O)C(NC(=O)c2ccc(NC=O)cc2O)C(C)OC(=O)C1CCCC NQWZLRAORXLWDN-UHFFFAOYSA-N 0.000 description 2
- 241000193738 Bacillus anthracis Species 0.000 description 2
- 241000194108 Bacillus licheniformis Species 0.000 description 2
- 108010078791 Carrier Proteins Proteins 0.000 description 2
- 102000011687 Electron Transport Complex II Human genes 0.000 description 2
- 108010076322 Electron Transport Complex II Proteins 0.000 description 2
- 108020000311 Glutamate Synthase Proteins 0.000 description 2
- 244000017020 Ipomoea batatas Species 0.000 description 2
- 235000002678 Ipomoea batatas Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- VZUNGTLZRAYYDE-UHFFFAOYSA-N N-methyl-N'-nitro-N-nitrosoguanidine Chemical compound O=NN(C)C(=N)N[N+]([O-])=O VZUNGTLZRAYYDE-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- UIFFUZWRFRDZJC-SBOOETFBSA-N antimycin A Chemical compound C[C@H]1OC(=O)[C@H](CCCCCC)[C@@H](OC(=O)CC(C)C)[C@H](C)OC(=O)[C@H]1NC(=O)C1=CC=CC(NC=O)=C1O UIFFUZWRFRDZJC-SBOOETFBSA-N 0.000 description 2
- PVEVXUMVNWSNIG-UHFFFAOYSA-N antimycin A3 Natural products CC1OC(=O)C(CCCC)C(OC(=O)CC(C)C)C(C)OC(=O)C1NC(=O)C1=CC=CC(NC=O)=C1O PVEVXUMVNWSNIG-UHFFFAOYSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229940065181 bacillus anthracis Drugs 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
- WDRWZVWLVBXVOI-QTNFYWBSSA-L dipotassium;(2s)-2-aminopentanedioate Chemical compound [K+].[K+].[O-]C(=O)[C@@H](N)CCC([O-])=O WDRWZVWLVBXVOI-QTNFYWBSSA-L 0.000 description 2
- 229960003276 erythromycin Drugs 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000009036 growth inhibition Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229910000358 iron sulfate Inorganic materials 0.000 description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 229940099596 manganese sulfate Drugs 0.000 description 2
- 239000011702 manganese sulphate Substances 0.000 description 2
- 235000007079 manganese sulphate Nutrition 0.000 description 2
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 229910052751 metal Chemical class 0.000 description 2
- 239000002184 metal Chemical class 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000013919 monopotassium glutamate Nutrition 0.000 description 2
- 235000013557 nattō Nutrition 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000013587 production medium Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 102100023912 40S ribosomal protein S12 Human genes 0.000 description 1
- IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 101100243636 Bacillus subtilis (strain 168) pgdS gene Proteins 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 235000000378 Caryota urens Nutrition 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 240000000163 Cycas revoluta Species 0.000 description 1
- 235000008601 Cycas revoluta Nutrition 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000012766 Growth delay Diseases 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 235000010103 Metroxylon rumphii Nutrition 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 229940087098 Oxidase inhibitor Drugs 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- VIROVYVQCGLCII-UHFFFAOYSA-N amobarbital Chemical compound CC(C)CCC1(CC)C(=O)NC(=O)NC1=O VIROVYVQCGLCII-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 101150106096 gltA gene Proteins 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000008729 phenylalanine Nutrition 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 108010092841 ribosomal protein S12 Proteins 0.000 description 1
- 229940080817 rotenone Drugs 0.000 description 1
- JUVIOZPCNVVQFO-UHFFFAOYSA-N rotenone Natural products O1C2=C3CC(C(C)=C)OC3=CC=C2C(=O)C2C1COC1=C2C=C(OC)C(OC)=C1 JUVIOZPCNVVQFO-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 101150051331 ywrD gene Proteins 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/14—Glutamic acid; Glutamine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
本発明の更なる目的は、前記電子伝達系阻害剤が、NADH-ユビキノンレダクターゼ阻害剤、コハク酸−ユビキノンレダクターゼ阻害剤、ユビキノール−シトクロムcレダクターゼ阻害剤、シトクロムcオキシダーゼ阻害剤、およびそれらの組合せからなる群から選ばれる物質である、前記ポリ−γ−グルタミン酸の製造法を提供することである。
本発明の更なる目的は、前記電子伝達系阻害剤が、テノイルトリフルオロアセトン(TTFA)、カプサイシン、アジ化ナトリウム、リドカイン、ヒドロキシルアミン、o−メチルヒドロキシルアミン、およびそれらの組合せからなる群から選ばれる物質である、前記ポリ−γ−グルタミン酸の製造法を提供することである。
本発明の更なる目的は、前記微生物がバチルス・ズブチリスである前記ポリ−γ−グルタミン酸の製造法を提供することである。
本発明の更なる目的は、ポリ−γ−グルタミン酸生産能を有し、かつ電子伝達系阻害剤に耐性を有するように改変したバチルス属に属する微生物を提供することである。
本発明の更なる目的は、バチルス・ズブチリスである前記微生物を提供することである。
本発明により、効率的なポリ−γ−グルタミン酸の製造方法が提供される。また、本発明により、電子伝達系阻害剤に耐性を有する新規細菌が提供され、この細菌を用いる、効率的なポリ−γ−グルタミン酸の製造が可能となる。
本明細書において、「ポリ−γ−グルタミン酸生産能」とは、ポリ−γ−グルタミン酸を生産し、菌体外に蓄積する能力を意味する。
Type Culture Collection、住所 10801 University Boulevard, Manassas, VA 20110, United States of America)から購入することができる。
リ−γ−グルタミン酸生産能を向上させたバチルス属微生物は、ポリ−γ−グルタミン酸分解活性を低下又は消失させることによっても取得することができる(特開2003−235566号公報、米国特許公開第20030175936号、特開2003−230384号公報)。
本発明に用いる細菌は、ポリ−γ−グルタミン酸を菌体外に生産する能力を持つバチルス属細菌に電子伝達系阻害剤耐性を付与することにより取得される。「電子伝達系阻害剤耐性」とは、電子伝達系阻害剤耐性を有さないバチルス属細菌、例えばバチルス属細菌の野生株又は非改変株が生育できない濃度の電子伝達系阻害剤を含む培地で生育できること、及び、電子伝達系阻害剤を含む培地でバチルス属細菌の野生株又は非改変株よりも生育速度が速いことをいう。具体的には例えば、バチルス属細菌の生育に好適な寒天培地、例えばLB寒天培地に電子伝達系阻害剤を添加した培地に細菌を接種し、好適な温度で培養した場合、バチルス属細菌の野生株又は非改変株が2日後にコロニーを形成しないときに、2日以内にコロニーを形成する菌株は、電子伝達系阻害剤耐性を有する。前記好適な温度とは、電子伝達系阻害剤を含まない培地で培養したときに、良好な生育を示す温度である。あるいは、0.1mM〜10mMの濃度の電子伝達系阻害剤、例えばテノイルトリフルオロアセトン(TTFA)、カプサイシンを含む寒天培地で、2日以内にコロニーを形成する菌株は、電子伝達系阻害剤耐性を有する。
微生物の電子伝達系は、NADH−ユビキノンレダクターゼ複合体、コハク酸−ユビキノンレダクターゼ複合体、ユビキノール−シトクロムcレダクターゼ複合体、シトクロムcオキシダーゼ複合体から構成されており、各複合体に特異的な阻害剤が知られている(Helmward Zollner編、Handbook of enzyme inhibitors, Wiley-VCH (1999))。例えばNADH−ユビキノンレダクターゼ阻害剤としてはロテノン、カプサイシン、アミタール及びアクリノールが、コハク酸−ユビキノンレダクターゼ阻害剤としてはアンチマイシンAおよびシナリジンが、ユビキノール−シトクロムcレダクターゼ阻害剤としてはアンチマイシンA、ジフェニルアミンおよびテノイルトリフルオロアセトン(TTFA)、シトクロムcオキシダーゼ阻害剤としてはアジ化ナトリウム、リドカイン、シアン化カリウム、ヒドロキシルアミン及びo−メチルヒドロキシルアミンが挙げられる。これらの阻害剤の中で、TTFA、カプサイシン、アジ化ナトリウム、リドカイン、ヒドロキシルアミン、o−メチルヒドロキシルアミン、そしてこれらの組み合わせが好ましく使用される。以下に、各種電子伝達系阻害剤耐性を有するバチルス属細菌を取得する方法の例について説明する。
よい。また、選択は、1種の電子伝達系阻害剤について1回でもよく、複数回行ってもよい。
S. Tokuyama, Y. Tahara, J. Bacteriol., 184: 337-343, 2002)。したがって、バチルス属細菌にストレプトマイシンおよび/またはエリスロマイシンへの耐性変異を付与することにより、さらにポリ−γ−グルタミン酸の生産能を増強することができる可能性がある。
ポリ−γ−グルタミン酸生産能を有し、かつ電子伝達系阻害剤に耐性を有するバチルス属細菌を培養することにより、培養液中に際立った量のポリ−γ−グルタミン酸が生成蓄積される。電子伝達系阻害剤に対する耐性を付与することでポリ−γ−グルタミン酸の生産性や蓄積量が向上する理由は、培地への酸素供給速度が低下した状態において電子伝達系と共役した酸化的リン酸化によるATP産生効率が低下しにくくなったためと推定される。
、アラニン、ロイシン、フェニルアラニン、ヒスチジンなど、またビタミン類としてはビオチン、サイアミンなどを用いることができる。
また、培養期間は、通常2〜4日間程度でよい。また、固体培養の場合においても前記液体培養の場合と同様に、培養温度は25〜50℃、好ましくは37〜42℃、培養時のpHは5〜9、好ましくはpH6〜8が採用される。このようにして培養すると、ポリ−γ−グルタミン酸は、主として菌体外に分泌されて培養物中に蓄積される。
ポリ−γ−グルタミン酸生産能を有するバチルス・ズブチリスNBRC16449を、50mlのLB培地(トリプトン 10 g/L、酵母エキス 5 g/L、NaCl 10 g/L、pH 7.0)を入れた500ml坂口フラスコに植菌し、30℃にて一晩振盪培養した後、集菌した。
カラム:Asahipak GF7M HQ (7.6 × 300 mm) + Asahipak GS-1G(7.6 × 50 mm) (shodex社製)
移動層:10 mM Tris-HClバッファー(pH 8.6), 10 g/l NaCl
流速:0.9 ml/min
検出:UV220nm
温度:50℃
注入量:30 μl
平均分子量30 kDaのポリ−γ−グルタミン酸(味の素製)を標準品として用い、面積比からポリ−γ−グルタミン酸量を算出した。
実施例1で取得した上記9株(C10、C20、C32、T3、T28、T25、N20、N28およびN38)および親株のバチルス・ズブチリスNBRC16449株を3mlの前培養培地(2% グルコース、0.4%硫酸アンモニウム、0.4% KH2PO4、0.03%硫酸マグネシウム、0.001%硫酸鉄、0.002%硫酸マンガン、27 ml/l大豆塩酸加水分解液(
総窒素3.5%を含む)、水酸化カリウムでpH7.0に調整)に植菌し、37℃で16時間培養した。
Claims (2)
- A)ポリ−γ−グルタミン酸生産能を有し、かつ電子伝達系阻害剤に耐性を有するバチルス属微生物を培地中で培養すること、および
B)培地からポリ−γ−グルタミン酸を採取すること、を含むポリ−γ−グルタミン酸の製造法であって、
前記電子伝達系阻害剤が、テノイルトリフルオロアセトン(TTFA)、カプサイシン、アジ化ナトリウム、およびそれらの組合せからなる群から選ばれる物質である、製造法。 - 前記微生物がバチルス・ズブチリスである請求項1に記載のポリ−γ−グルタミン酸の製造法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2005116163/13A RU2313578C2 (ru) | 2005-05-30 | 2005-05-30 | Способ получения поли-гамма-глутаминовой кислоты и микроорганизм, используемый в указанном способе |
RU2005116163 | 2005-05-30 | ||
US74065605P | 2005-11-30 | 2005-11-30 | |
US60/740,656 | 2005-11-30 | ||
PCT/JP2006/311169 WO2006129835A1 (en) | 2005-05-30 | 2006-05-30 | METHOD FOR PRODUCING POLY-gamma-GLUTAMIC ACID AND MICROORGANISM USED IN THE PRODUCTION METHOD |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2008541694A JP2008541694A (ja) | 2008-11-27 |
JP2008541694A5 JP2008541694A5 (ja) | 2009-05-28 |
JP4985407B2 true JP4985407B2 (ja) | 2012-07-25 |
Family
ID=36759027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007555359A Expired - Fee Related JP4985407B2 (ja) | 2005-05-30 | 2006-05-30 | ポリ−γ−グルタミン酸の製造法及びその製造法に用いられる微生物 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP4985407B2 (ja) |
WO (1) | WO2006129835A1 (ja) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0411894A (ja) * | 1990-04-27 | 1992-01-16 | Nippon Zeon Co Ltd | ビオチンの製造法 |
KR100327561B1 (ko) * | 1999-12-29 | 2002-03-15 | 윤덕용 | 고점도 발효액으로부터 폴리글루탐산의 제조방법 |
JP4380029B2 (ja) * | 2000-07-05 | 2009-12-09 | 味の素株式会社 | 微生物を利用した物質の製造法 |
JP2003235566A (ja) * | 2002-02-08 | 2003-08-26 | Ajinomoto Co Inc | ポリ−γ−グルタミン酸分解酵素遺伝子およびポリ−γ−グルタミン酸の製造法 |
-
2006
- 2006-05-30 JP JP2007555359A patent/JP4985407B2/ja not_active Expired - Fee Related
- 2006-05-30 WO PCT/JP2006/311169 patent/WO2006129835A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2006129835A1 (en) | 2006-12-07 |
JP2008541694A (ja) | 2008-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7156594B2 (ja) | 1ステップ発酵による(r)-3-ヒドロキシ酪酸またはその塩の調製 | |
JP4815493B2 (ja) | コチュジャン発酵物、醸造醤油原液、または酸分解醤油原液を含有する培地組成物、及びγ−アミノブチル酸の生産方法 | |
JP4864138B2 (ja) | コリネバクテリウムグルタミカムを用いたl−アルギニン生産方法 | |
KR102372949B1 (ko) | 부티르산 산생균 및 그 이용 | |
Todorov et al. | Influence of growth conditions on the production of a bacteriocin by Lactococcus lactis subsp. lactis ST34BR, a strain isolated from barley beer | |
KR20190066129A (ko) | 글리세롤로부터 루테린을 고생산하는 락토바실러스 루테리 oh0335 균주 및 이의 용도 | |
JPWO2007097374A1 (ja) | γ−アミノ酪酸生産能を有する乳酸菌 | |
JP4173368B2 (ja) | 5’−イノシン酸を高収率で生産する微生物のコリネバクテリウム・アンモニアゲネスcjip009及びそれを用いた5’−イノシン酸の生産方法 | |
JPH07289284A (ja) | 光学活性4−ヒドロキシ−2−ケトグルタル酸の製造法 | |
WO2006013736A1 (ja) | 酵母変異株、グルタチオン高含有酵母の製造方法、その培養物、その分画物、酵母エキスおよびグルタチオン含有飲食品 | |
JP4985407B2 (ja) | ポリ−γ−グルタミン酸の製造法及びその製造法に用いられる微生物 | |
JP3848297B2 (ja) | リボフラビンを生産する微生物及びこれを用いたリボフラビンの生産方法 | |
Buckel et al. | Clostridium viride sp. nov., a strictly anaerobic bacterium using 5-aminovalerate as growth substrate, previously assigned to Clostridium aminovalericum | |
KR101548640B1 (ko) | 엽산생성능이 우수한 신규한 락토바실러스 플랜타룸 ja71 균주 | |
JP6483253B2 (ja) | L−グルタミンを生産する微生物、及びそれを利用したl−グルタミン生産方法 | |
JP3926292B2 (ja) | リボフラビンを生産する微生物及びこれを用いたリボフラビンの生産方法 | |
JP4620404B2 (ja) | 酵母変異株、グルタチオン高含有酵母の製造方法、その培養物、その分画物、酵母エキスおよびグルタチオン含有飲食品 | |
Von Mollendorff et al. | Optimization of growth medium for production of bacteriocins produced by Lactobacillus plantarum JW3BZ and JW6BZ, and Lactobacillus fermentum JW11BZ and JW15BZ isolated from boza. | |
JPH08242880A (ja) | ガンマーポリグルタミン酸の生産法 | |
JP2816422B2 (ja) | 微生物による5−アミノレブリン酸の製造方法 | |
RU2313578C2 (ru) | Способ получения поли-гамма-глутаминовой кислоты и микроорганизм, используемый в указанном способе | |
RU2003137558A (ru) | Получение биологически доступной фолиевой кислоты | |
JPH0584067A (ja) | 発酵法によるイノシンの製造法 | |
JP3841495B2 (ja) | L−乳酸生産能及びtnf産生誘導活性を有する乳酸菌 | |
KR100542563B1 (ko) | 리보플라빈을 생산하는 미생물 및 이를 이용한 리보플라빈의 생산방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090413 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090413 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110712 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110907 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111122 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120116 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120403 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120416 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4985407 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150511 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150511 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |